NEW YORK, March 12, 2013 - vb-news.net, one of the leaders in providing investment alerts on U.S. stocks are announcing Investment Highlights on Merck & Co, Pfizer Inc, Intel Corporation
An independent monitoring board has said that no major safety issues have been detected with Merck & Co., Inc.(NYSE:MRK)’s Vytorin cholesterol drug and studies on it can continue.
Investors have been waiting for an update from the panel on the study of Vytorin, called IMPROVE-IT, which began in 2005 and involves more than 18,000 patients with controlled cholesterol who either had heart attacks or chest pain that comes before heart attacks.
Is MRK a Buy After Today’s Solid Gain? Find Out Here http://vbtrendreport.com/aw/?code=MRK
The study will continue until September 2014 and aims to prove conclusively whether Vytorin can significantly reduce heart attacks, strokes and heart-related deaths compared with the generically-available Zocor (simvastatin) cholesterol fighter. Vytorin combines Zocor with Zetia. Zetia and Zocor block "bad" LDL cholesterol in different ways.
Merck investors are hoping the final results next year will prove Vytorin's clear effectiveness and safety, and revive sales of Vytorin and Zetia. Vytorin’s annual sales total $1.75 billion while Zetia’s sales amount to $2.6 billion a year.
Merck shares were changing hands at $45.26 in morning trade, up $1.60 or 3.7 percent on the New York Stock Exchange.
Meanwhile another pharma company Pfizer Inc.(NYSE:PFE) has said that it has filed suit against six firms, over patent infringement of celecoxib, the active ingredient of its Celebrex used for treating osteoarthritis.
How Should Investors Trae PFE after The Recent Momentum? Get Free Trend Analysis Here http://vbtrendreport.com/aw/?code=PFE
Earlier, the United States Patent & Trademark Office had granted Pfizer a reissue patent covering methods of treating osteoarthritis and some other conditions with celecoxib.
Pfizer’s statement on its website: "Pfizer filed suit today against Teva Pharmaceuticals USA, Inc, Mylan Pharmaceuticals Inc, Watson Laboratories Inc, Lupin Pharmaceuticals, USA, Inc, Apotex Corp, and Apotex Inc in the United States District Court for the Eastern District of Virginia for infringement of the reissue patent."
The reissue patent expires on December 2, 2015, and includes six months of pediatric exclusivity. The basic patent for the drug expires on May 30, 2014, and also includes six months of pediatric exclusivity.
Intel Corporation(NASDAQ:INTC) which is getting into the chip contracting business is likely to obtain as much as 10 percent of Apple's next-generation mobile chip orders.
Get Latest News, Rumors and Updates on INTC Here http://vbtrendreport.com/aw/?code=INTC
Intel could be vying for Apple's business for its "A7" chip, expected to power the next-generation iPhone. Samsung handles Apple’s current A-series chips and the iPhone maker wants to shift business away from the South Korean company.
Taiwan Semiconductor Manufacturing Company (TSMC) might be the likely choice for at least part of the production and according to reports, it might start production of A-series chips in 2014.
Samsung might receive 50 percent of the "A7" orders, TSMC might get 40 percent, and Intel is likely to take the remaining 10 percent.
There were reports earlier that Intel was in talks with Apple to build next-generation chips for the iPhone and iPad.
About vb-news.netvb-news.net’s team is engaged in providing stock newsletters on various hot penny stocks on a regular basis. Our instant stock news on Major Gainers, small cap penny stocks and various other stocks, guides investors in making the wise stock market investments decision. In order to get update to the markets, we would advise you sign up to our free newsletters. You can become leader in stock market by keeping track of the daily activity.
The assembled information disseminated by vb-news.net is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. vb-news.net does expect that investors will buy and sell securities based on information assembled and presented in vb-news.net. PLEASE always do your own due diligence, and consult your financial advisor.
vb-news.net 1419 Westwood Blvd Los Angeles, CA90024email@example.com
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here